Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study was terminated early due to slow enrollment and difficulties with long-term follow-up
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
An evaluation of the incidence of complications resulting from far lateral spine surgery utilizing the K2M RAVINE® Lateral Access System (RAVINE) with ALEUTIAN® Lateral Interbody Spacer System versus literature reported results for the NuVasive XLIF® system (XLIF) in the treatment of degenerative disc disease (DDD) with up to Grade 1 spondylolisthesis.
An evaluation of the incidence of complications resulting from far lateral spine surgery utilizing the K2M RAVINE® Lateral Access System (RAVINE) with ALEUTIAN® Lateral Interbody Spacer System versus literature reported results for the NuVasive XLIF® system (XLIF) in the treatment of degenerative disc disease (DDD) with up to Grade 1 spondylolisthesis at L2-S1 requiring surgical intervention at one or two contiguous levels. Safety will be assessed by the following: 1.) Evaluation of all adverse events including device related, procedure related and additional serious adverse events; 2.) Additional surgical intervention at the operative site including the need for removals, revisions, re-operations or supplemental fixation required to modify the device; and 3.) The incidence and severity of any psoas muscle injury, genital femoral nerve injury and lumbar plexus injury will be determined for all patients. Supplemental fixation of any kind may be included as long as the procedure is completed via a minimally invasive approach.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Visual Analog Scale (VAS) Change From Baseline | Evaluation of the change of the Back VAS, Hip VAS and the Leg VAS at the 24 month post-operative visit as compared to pre-op time periods. Information on all reports of pain/numbness/tingling and the location of symptoms were captured and evaluated. VAS scale ranged from 0 - 10cm with the 10cm accounting for the highest level of pain. | 24 months |
| Number of Patients With Adverse Events AEs) | The evaluation of all adverse events including device related, procedure related and additional serious adverse events. | Operative to 24 month |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Pain/Dysesthesia Score From Baseline (Pre-Operative) | Neurological evaluation of the patient, with specific evaluation of psoas muscle weakness, radiating radicular pain, knee extension weakness, dorsiflexion weakness, plantarflexion weakness and anterior thigh numbness was performed using Patient symptom Questionnaire (0-100mm analog scale with 100mm being the highest pain/weakness/numbness) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients eligible for study enrollment will have a primary diagnoses limited to degenerative disc disease (DDD) with up to Grade 1 spondylolisthesis at L2-S1 requiring surgical intervention at one or two contiguous levels. Qualified patients will have confirmed failure of conservative therapy as well as plain film imaging studies. Subjects must be ≥ 18 years old at the time of enrollment.
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 23213282 | Background | Malham GM, Ellis NJ, Parker RM, Seex KA. Clinical outcome and fusion rates after the first 30 extreme lateral interbody fusions. ScientificWorldJournal. 2012;2012:246989. doi: 10.1100/2012/246989. Epub 2012 Nov 1. | |
| 23049476 | Background | Caputo AM, Michael KW, Chapman TM Jr, Massey GM, Howes CR, Isaacs RE, Brown CR. Clinical outcomes of extreme lateral interbody fusion in the treatment of adult degenerative scoliosis. ScientificWorldJournal. 2012;2012:680643. doi: 10.1100/2012/680643. Epub 2012 Sep 24. |
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | K2M RAVINE Lateral Access System | This treatment group included patients treated with the RAVINE system that had:
|
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Demographics and Baseline Characteristics | This is a demographic and baseline characteristics of the patient population. This includes parameters such as Age, Gender, Height, Weight Body Mass Index (BMI) and Tobacco Usage. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Visual Analog Scale (VAS) Change From Baseline | Evaluation of the change of the Back VAS, Hip VAS and the Leg VAS at the 24 month post-operative visit as compared to pre-op time periods. Information on all reports of pain/numbness/tingling and the location of symptoms were captured and evaluated. VAS scale ranged from 0 - 10cm with the 10cm accounting for the highest level of pain. | All patients were accounted for | Posted | Mean | Standard Deviation | score on a scale | 24 months |
|
Operative to 24+ Months
Any untoward medical occurrence in a subject undergoing surgery in this trial which does not necessarily have a causal relationship with this intervention. An AE can, therefore, be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of the one of the devices. Any AE that occurs during the subject's participation in the study will be recorded on the Adverse Event case report form.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Participants With Adverse Events | Participants were evaluated for all adverse events including device related, procedure related, and additional serious adverse events. 9 of the 30 SAE participants did not experience a non-SAE events. The other 21 participants had events in both categories. The study did not establish a frequency threshold, therefore, all AEs are listed. |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Cardiac failure | Cardiac disorders | MedDRA (Unspecified) | Systematic Assessment |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Anaemia postoperative | Blood and lymphatic system disorders | MedDRA (Unspecified) | Systematic Assessment |
Early termination leading to small numbers of subjects analyzed.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Marissa Conrad, Senior Director of Clinical and Medical Affairs | Stryker Spine | 201-749-8162 | marissa.conrad@stryker.com |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Feb 27, 2017 | Jan 12, 2021 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D055959 | Intervertebral Disc Degeneration |
| D013168 | Spondylolisthesis |
| ID | Term |
|---|---|
| D013122 | Spinal Diseases |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
| D013169 | Spondylolysis |
Not provided
Not provided
Not provided
Not provided
Not provided
| time of discharge, an average of 4.5 days, up to 8 weeks post-operatively, 3 months, 6 months, 12 months, 24 months |
| Change in Oswestry Disability Index From Baseline (Pre-Operative) | The Oswestry Disability Index (ODI) is a validated instrument including items that relate to subjective symptomatology and activities of daily living (pain intensity, personal care, lifting, walking, sitting, standing, sex life, traveling). This patient-reported outcome measure is a 10 item questionnaire that evaluates disability and functional impairment associated with back problems. Each item is scored from O up to 5, with higher scores corresponding to greater disability. A total ODI score is determined by adding the scores of the individual questions and dividing that total by the maximum possible score (i.e., 50 if all questions are answered) to yield a percentage. Therefore, the ODI score ranges from 0% to 100%. | time of discharge, an average of 4.5 days, up to 8 weeks post-operatively, 3 months, 6 months, 12 months, 24 months |
| Change in Health-Related Quality of Life From Baseline (Pre-op) | Health-related quality of life was evaluated in all study subjects using the SF-12v2 Health Survey. This shortened and simplified version of the SF-36 makes the questionnaire less ambiguous for patients. It has a self-administered form that makes it easy to read and complete, and that reduces missing responses. The physical and mental component summary scales, referred to as PCS-12 and MCS-12 were evaluated against published normative values and a 15% improvement in these scores was used as an assessment of success. In calculating the true value of a treatment, the scores from the SF-12v2 were converted into a utility index (SF-6D), which considered not only how many years a medical intervention could have added to a patient's life, but also the quality of that life. Use of the SF-6D did not expand the questions administered to the patients. The scale ranged from 0-100% with 100% being the best quality of life. | time of discharge, an average of 4.5 days, up to 8 weeks post-operatively, 3 months, 6 months, 12 months, 24 months |
| Radiographic Assessments | Quantitative and qualitative radiographic assessment of the pre and post-operative AP, and Lateral, Flexion/Extension images were performed. Radiographic and qualitative assessments performed include:
| 12 mo to 24 mo |
| Patient Satisfaction | At the 12 month and 24 month follow-up visits, subjects were asked whether they were satisfied with the outcome of their surgery (Yes/No) and whether they would repeat the operation (Yes/No). | 12 month and 24 month |
| Odom's Criteria | At the 24 month follow-up visit, the Investigator rated the clinical disposition of each study subject according to Odom's Criteria as follows: Excellent: all pre-operative symptoms relieved, able to carry out daily occupations without impairment. Good: minimum persistence of pre-operative symptoms, able to carry out daily occupations without significant interference. Fair/Satisfactory: relief of some pre-operative symptoms but physical activity is significantly limited. Poor: symptoms or signs unchanged or worse. | 24 months |
| Surgery Time | The length of the surgical procedure from the initial incision to final closure were captured from the Anesthesia Record. | During operation. |
| Anesthesia Time | The length of time the patient is under anesthesia were captured from the Anesthesia Record. | During operation. |
| Estimated Blood Loss | The amount of blood loss over the entire length of the surgery, documented on the Anesthesia Record, was captured. | During Operation |
| Number of Participants With Abnormal Neuromonitoring System Results | Abnormal result(s) of neuromonitoring systems (Train of Four, Electromyography (EMG), Triggered EMG, Somato Sensory Evoked Potential (SSEP) and Motor Evoked Potential (MEP)) utilized during the surgery were captured. | During operation |
| Length of Hospital Stay | The length of hospital stay from the date of hospital admission to the date of discharge was calculated. | From admission to discharge |
| Change in Work/School Status Compared to Baseline | The ability to and the time it takes for the subject to be cleared to return to work/school from the date of surgery was documented. | Pre-operative to 24 months |
| Change in Use of Narcotics Post-Surgery Compared to Baseline | The types and dosages of any narcotics taken by the patient post-surgery were documented. | Pre-operative to 24 months |
| 21160394 | Background | Youssef JA, McAfee PC, Patty CA, Raley E, DeBauche S, Shucosky E, Chotikul L. Minimally invasive surgery: lateral approach interbody fusion: results and review. Spine (Phila Pa 1976). 2010 Dec 15;35(26 Suppl):S302-11. doi: 10.1097/BRS.0b013e3182023438. |
| 22402840 | Background | Berjano P, Balsano M, Buric J, Petruzzi M, Lamartina C. Direct lateral access lumbar and thoracolumbar fusion: preliminary results. Eur Spine J. 2012 May;21 Suppl 1(Suppl 1):S37-42. doi: 10.1007/s00586-012-2217-z. Epub 2012 Mar 9. |
| Participants |
|
| Age, Continuous | Mean | Standard Deviation | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race (NIH/OMB) | The study Case Report Forms did not include Race/Ethnicity | Count of Participants | Participants |
|
| Region of Enrollment | Count of Participants | Participants |
|
| Body Mass Index (BMI) | Mean | Standard Deviation | lbs/(in^2)*703 |
|
| Height | Mean | Standard Deviation | inches |
|
| Weight | Mean | Standard Deviation | pounds |
|
| Tobacco Use | Count of Participants | Participants |
|
Evaluation of the improvement of the Left Hip VAS at the 24 month post-operative visit as compared to pre-op time periods. Information on all reports of pain/numbness/tingling and the location of symptoms was captured and evaluated. |
| OG002 | Right Hip | Evaluation of the improvement of the Right Hip VAS at the 24 month post-operative visit as compared to pre-op time periods. Information on all reports of pain/numbness/tingling and the location of symptoms was captured and evaluated. |
| OG003 | Left Leg | Evaluation of the improvement of the Left Leg VAS at the 24 month post-operative visit as compared to pre-op time periods. Information on all reports of pain/numbness/tingling and the location of symptoms was captured and evaluated. |
| OG004 | Right Leg | Evaluation of the improvement of the Right Leg VAS at the 24 month post-operative visit as compared to pre-op time periods. Information on all reports of pain/numbness/tingling and the location of symptoms was captured and evaluated. |
|
|
| Primary | Number of Patients With Adverse Events AEs) | The evaluation of all adverse events including device related, procedure related and additional serious adverse events. | This is an analysis of the number of participants that reported any form of adverse event. Participants were evaluated for all adverse events including device related, procedure related, and additional serious adverse events. 9 of the 30 SAE participants did not experience a non-SAE events. The other 21 participants had events in both categories | Posted | Number | participants | Operative to 24 month |
|
|
|
| Secondary | Change in Pain/Dysesthesia Score From Baseline (Pre-Operative) | Neurological evaluation of the patient, with specific evaluation of psoas muscle weakness, radiating radicular pain, knee extension weakness, dorsiflexion weakness, plantarflexion weakness and anterior thigh numbness was performed using Patient symptom Questionnaire (0-100mm analog scale with 100mm being the highest pain/weakness/numbness) | The overall number of patients participated in each interval differed from the number of patients that were evaluated for the body location measurements. | Posted | Mean | Standard Deviation | score on a scale | time of discharge, an average of 4.5 days, up to 8 weeks post-operatively, 3 months, 6 months, 12 months, 24 months |
|
|
|
| Secondary | Change in Oswestry Disability Index From Baseline (Pre-Operative) | The Oswestry Disability Index (ODI) is a validated instrument including items that relate to subjective symptomatology and activities of daily living (pain intensity, personal care, lifting, walking, sitting, standing, sex life, traveling). This patient-reported outcome measure is a 10 item questionnaire that evaluates disability and functional impairment associated with back problems. Each item is scored from O up to 5, with higher scores corresponding to greater disability. A total ODI score is determined by adding the scores of the individual questions and dividing that total by the maximum possible score (i.e., 50 if all questions are answered) to yield a percentage. Therefore, the ODI score ranges from 0% to 100%. | 131 patients started the study at Pre-op, 6 patients did not complete the survey; 125 started operative, 34 patients did not complete the survey at Discharge; 121 started the Post-operative interval, 4 patients did not complete the survey; 111 patients started at 3 Month interval, 4 patients did not complete the survey; All patients who started at 6 months and 24 months completed their surveys at their respective intervals. | Posted | Mean | Standard Deviation | score on a scale | time of discharge, an average of 4.5 days, up to 8 weeks post-operatively, 3 months, 6 months, 12 months, 24 months |
|
|
|
| Secondary | Change in Health-Related Quality of Life From Baseline (Pre-op) | Health-related quality of life was evaluated in all study subjects using the SF-12v2 Health Survey. This shortened and simplified version of the SF-36 makes the questionnaire less ambiguous for patients. It has a self-administered form that makes it easy to read and complete, and that reduces missing responses. The physical and mental component summary scales, referred to as PCS-12 and MCS-12 were evaluated against published normative values and a 15% improvement in these scores was used as an assessment of success. In calculating the true value of a treatment, the scores from the SF-12v2 were converted into a utility index (SF-6D), which considered not only how many years a medical intervention could have added to a patient's life, but also the quality of that life. Use of the SF-6D did not expand the questions administered to the patients. The scale ranged from 0-100% with 100% being the best quality of life. | The number analyzed in Mental Health and Physical Health rows for 6 Months and 12 Months differ due to the inability for a participant to complete the required forms for those two intervals. | Posted | Mean | Standard Deviation | score on a scale | time of discharge, an average of 4.5 days, up to 8 weeks post-operatively, 3 months, 6 months, 12 months, 24 months |
|
|
|
| Secondary | Radiographic Assessments | Quantitative and qualitative radiographic assessment of the pre and post-operative AP, and Lateral, Flexion/Extension images were performed. Radiographic and qualitative assessments performed include:
| The numbers are different from the overall number analyzed due to the different number of people who participated in each visit's radiographic analysis | Posted | Count of Participants | Participants | 12 mo to 24 mo |
|
|
|
| Secondary | Patient Satisfaction | At the 12 month and 24 month follow-up visits, subjects were asked whether they were satisfied with the outcome of their surgery (Yes/No) and whether they would repeat the operation (Yes/No). | Patient self-assessment of the procedure at 12M and 24M | Posted | Count of Participants | Participants | 12 month and 24 month |
|
|
|
| Secondary | Odom's Criteria | At the 24 month follow-up visit, the Investigator rated the clinical disposition of each study subject according to Odom's Criteria as follows: Excellent: all pre-operative symptoms relieved, able to carry out daily occupations without impairment. Good: minimum persistence of pre-operative symptoms, able to carry out daily occupations without significant interference. Fair/Satisfactory: relief of some pre-operative symptoms but physical activity is significantly limited. Poor: symptoms or signs unchanged or worse. | Posted | Count of Participants | Participants | 24 months |
|
|
|
| Secondary | Surgery Time | The length of the surgical procedure from the initial incision to final closure were captured from the Anesthesia Record. | 3 of 125 subjects did not have surgery time included. There were 12 staged procedures increasing the overall number of procedures to 134 | Posted | Mean | Standard Deviation | Minutes | During operation. | surgeries | surgeries |
|
|
|
| Secondary | Anesthesia Time | The length of time the patient is under anesthesia were captured from the Anesthesia Record. | 3 of 125 subjects did not have surgery time included. There were 12 staged procedures increasing the overall number of procedures to 134 | Posted | Mean | Standard Deviation | Minutes | During operation. | surgeries | surgeries |
|
|
|
| Secondary | Estimated Blood Loss | The amount of blood loss over the entire length of the surgery, documented on the Anesthesia Record, was captured. | 11 of 125 subjects did not have blood loss included. There were 12 staged procedures increasing the overall number of procedures to 126. | Posted | Mean | Standard Deviation | Cubic Centimeters | During Operation | surgeries | surgeries |
|
|
|
| Secondary | Number of Participants With Abnormal Neuromonitoring System Results | Abnormal result(s) of neuromonitoring systems (Train of Four, Electromyography (EMG), Triggered EMG, Somato Sensory Evoked Potential (SSEP) and Motor Evoked Potential (MEP)) utilized during the surgery were captured. | Posted | Count of Participants | Participants | During operation |
|
|
|
| Secondary | Length of Hospital Stay | The length of hospital stay from the date of hospital admission to the date of discharge was calculated. | Posted | Mean | Standard Deviation | Days | From admission to discharge |
|
|
|
| Secondary | Change in Work/School Status Compared to Baseline | The ability to and the time it takes for the subject to be cleared to return to work/school from the date of surgery was documented. | All patients who participated in each interval were accounted for including the missing category | Posted | Count of Participants | Participants | Pre-operative to 24 months |
|
|
|
| Secondary | Change in Use of Narcotics Post-Surgery Compared to Baseline | The types and dosages of any narcotics taken by the patient post-surgery were documented. | All patients who participated in each interval were accounted for including the missing category | Posted | Count of Participants | Participants | Pre-operative to 24 months |
|
|
|
| 0 |
| 125 |
| 30 |
| 125 |
| 73 |
| 125 |
| Abdominal pain | Gastrointestinal disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Abdominal pain lower | Gastrointestinal disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Functional gastrointestinal disorder | Gastrointestinal disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Intestinal pseudo-obstruction | Gastrointestinal disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Small intestinal obstruction | Gastrointestinal disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Appendicitis | Infections and infestations | MedDRA (Unspecified) | Systematic Assessment |
|
| Postoperative wound infection | Infections and infestations | MedDRA (Unspecified) | Systematic Assessment |
|
| Adjacent segment degeneration | Injury, poisoning and procedural complications | MedDRA (Unspecified) | Systematic Assessment |
|
| Cerebrospinal fluid leakage | Injury, poisoning and procedural complications | MedDRA (Unspecified) | Systematic Assessment |
|
| Fall | Injury, poisoning and procedural complications | MedDRA (Unspecified) | Systematic Assessment |
|
| Fluid overload | Metabolism and nutrition disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Hyponatraemia | Metabolism and nutrition disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Groin pain | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Intervertebral disc space narrowing | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Muscular weakness | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Neck pain | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Cerebrovascular accident | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Cervical cord compression | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Cervical radiculopathy | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Dural tear | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Headache | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Lethargy | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Lumbar radiculopathy | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Lumbar spinal stenosis | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Metabolic encephalopathy | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Syncope | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Device dislocation | Product Issues | MedDRA (Unspecified) | Systematic Assessment |
|
| Confusional state | Psychiatric disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Bladder dysfunction | Renal and urinary disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Urinary retention | Renal and urinary disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Wound drainage | Surgical and medical procedures | MedDRA (Unspecified) | Systematic Assessment |
|
| Carpal tunnel decompression | Surgical and medical procedures | MedDRA (Unspecified) | Systematic Assessment |
|
| Cholecystectomy | Surgical and medical procedures | MedDRA (Unspecified) | Systematic Assessment |
|
| Inguinal hernia repair | Surgical and medical procedures | MedDRA (Unspecified) | Systematic Assessment |
|
| Medical device removal | Surgical and medical procedures | MedDRA (Unspecified) | Systematic Assessment |
|
| Pituitary tumour removal | Surgical and medical procedures | MedDRA (Unspecified) | Systematic Assessment |
|
| Spinal decompression | Surgical and medical procedures | MedDRA (Unspecified) | Systematic Assessment |
|
| Spinal fusion surgery | Surgical and medical procedures | MedDRA (Unspecified) | Systematic Assessment |
|
| Spinal laminectomy | Surgical and medical procedures | MedDRA (Unspecified) | Systematic Assessment |
|
| Bradycardia | Cardiac disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Ear pain | Ear and labyrinth disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Eyelid ptosis | Eye disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Vision blurred | Eye disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Abdominal discomfort | Gastrointestinal disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Abdominal hernia | Gastrointestinal disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Abdominal pain | Gastrointestinal disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Anorectal disorder | Gastrointestinal disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Constipation | Gastrointestinal disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Functional gastrointestinal disorder | Gastrointestinal disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Nausea | Gastrointestinal disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Asthenia | General disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Chest pain | General disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Discomfort | General disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Dysplasia | General disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Fat necrosis | General disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Fatigue | General disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Nodule | General disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Pain | General disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Pyrexia | General disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Swelling | General disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Tissue injury | General disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Hepatic lesion | Hepatobiliary disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Abscess | Infections and infestations | MedDRA (Unspecified) | Systematic Assessment |
|
| Appendicitis | Infections and infestations | MedDRA (Unspecified) | Systematic Assessment |
|
| Bronchitis | Infections and infestations | MedDRA (Unspecified) | Systematic Assessment |
|
| Upper respiratory tract infection | Infections and infestations | MedDRA (Unspecified) | Systematic Assessment |
|
| Urinary tract infection | Infections and infestations | MedDRA (Unspecified) | Systematic Assessment |
|
| Wound infection | Infections and infestations | MedDRA (Unspecified) | Systematic Assessment |
|
| Eye contusion | Injury, poisoning and procedural complications | MedDRA (Unspecified) | Systematic Assessment |
|
| Fall | Injury, poisoning and procedural complications | MedDRA (Unspecified) | Systematic Assessment |
|
| Joint injury | Injury, poisoning and procedural complications | MedDRA (Unspecified) | Systematic Assessment |
|
| Road traffic accidents | Injury, poisoning and procedural complications | MedDRA (Unspecified) | Systematic Assessment |
|
| skin laceration | Injury, poisoning and procedural complications | MedDRA (Unspecified) | Systematic Assessment |
|
| Osteoporosis | Metabolism and nutrition disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Bursitis | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Costochondritis | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Facet joint syndrome | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Gout | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Intervertebral disc degeneration | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Meniscus injury | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Muscle injury | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Muscle spasms | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Muscle tightness | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Muscular weakness | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Musculoskeletal pain | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Neck pain | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Pseuarthrosis | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Spinal compression fracture | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Spinal fracture | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Spinal osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Cervical radiculopathy | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Dural tear | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Dysaesthesia | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Headache | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Hypoaesthesia | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Lumbar radiculopathy | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Lumbar spinal stenosis | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Neuralgia | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Neuropathy peripheral | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Paraesthesia | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Peroneal nerve palsy | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Piriformis syndrome | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Spinal claudication | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Syncope | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Vertebral foraminal stenosis | Nervous system disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Device failure | Product Issues | MedDRA (Unspecified) | Systematic Assessment |
|
| Anxiety | Psychiatric disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Attention deficit / hyperactivity disorder | Psychiatric disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Depression | Psychiatric disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Obsessive-compulsive disorder | Psychiatric disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Bladder dysfunction | Renal and urinary disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Urinary retention | Renal and urinary disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Orchitis | Reproductive system and breast disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Testicular swelling | Reproductive system and breast disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Uterine leiomyoma | Reproductive system and breast disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Hypoxia | Respiratory, thoracic and mediastinal disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Cellulitis | Skin and subcutaneous tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Erythema | Skin and subcutaneous tissue disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Blepharoplasty | Surgical and medical procedures | MedDRA (Unspecified) | Systematic Assessment |
|
| Corneal suture | Surgical and medical procedures | MedDRA (Unspecified) | Systematic Assessment |
|
| Incisional drainage | Surgical and medical procedures | MedDRA (Unspecified) | Systematic Assessment |
|
| Spinal fusion | Surgical and medical procedures | MedDRA (Unspecified) | Systematic Assessment |
|
| Deep vein thrombosis | Vascular disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Ecchymosis | Vascular disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Haematoma | Vascular disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Haemorrhoidal haemorrhage | Vascular disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Rectal haemorrhage | Vascular disorders | MedDRA (Unspecified) | Systematic Assessment |
|
| Uterine haemorrhage | Vascular disorders | MedDRA (Unspecified) | Systematic Assessment |
|
The Institution/PI shall not disclose/use any confidential/proprietary information (CI) disclosed to/developed by the Institution during the study. Institution/PI agree to hold the results of the Study in confidence, and shall not disclose them except with prior written consent of K2M. Institution agrees to submit any Articles to K2M for review prior to publication and agrees to edit out any confidential information identified by K2M.
| D055009 |
| Spondylosis |
| Any AE : Procedure Related |
|
| Any AE : Device Related |
|
| Any AE : Mild |
|
| Any AE : Moderate |
|
| Any AE : Severe |
|
| Any Serious Adverse Event (SAE) |
|
| Any SAE : Procedure Related |
|
| Any SAE : Device Related |
|
| Any SAE : Mild |
|
| Any SAE : Moderate |
|
| Any SAE : Severe |
|
|
| Pain Above Right Knee |
|
|
| Left Groin Pain |
|
|
| Right Groin Pain |
|
|
| Flexing Left Hip Weakness |
|
|
| Flexing Right Hip Weakness |
|
|
| Extending Left Hip Weakness |
|
|
| Extending Right Hip Weakness |
|
|
| Left Hip Stairs Weakness |
|
|
| Right Hip Stairs Weakness |
|
|
| Left Hip Cross Leg Weakness |
|
|
| Right Hip Cross Leg Weakness |
|
|
|
| Physical Health |
|
|
| Partial Consolidation |
|
| Bridging / Fusion |
|
| Intact |
|
| Loosening |
|
| Fracture |
|
| Not Applicable |
|
| Unable to Assess |
|
| Subsidence |
|
| Migration |
|
| Subsidence & Migration |
|
| Other |
|
| 24 Month Fusion |
|
|
| 12 Month Hardware Condition |
|
|
| 24 Month Hardware Condition |
|
|
| 12 Month Cage Condition |
|
|
| 24 Month Cage Condition |
|
|
| Not Reported |
|
| Repeat Procedure |
|
| Not Reported |
|
| Not attending work/school by choice |
|
| Unable to go due to back/leg pain/conditions |
|
| Attending work/school with some restrictions |
|
| Attending work/school with no restrictions |
|
| Missing |
|
| Non-narcotics or NSAIDs |
|
| Intermittent short-acting narcotics |
|
| Chronic daily short-acting narcotics |
|
| Chronic daily long-acting narcotics |
|
| IV or injected narcotics |
|
| Missing |
|
| Non-Back Meds |
|